Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Vasculogenic Mimicry in Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study
- Status
- UNKNOWN
- Phase
- NA
A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Biological Effect of Vitamin D in Patients With Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
LITT and Pembrolizumab in Recurrent Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE1
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
- Status
- COMPLETED
- Phase
- N/A
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Diagnostic Values of Urothelial Carcinomas: Single-bolus Versus Split-bolus Computed Tomography Urography
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
Prospective Trial for Examining Hematuria Using Computed Tomography
- Status
- COMPLETED
- Phase
- NA